Abstract

Purpose To develop a patient-reported outcome measure for spasticity-related pain in children/adolescents (age 2–17 years) with cerebral palsy (CP), the ‘Questionnaire on Pain caused by Spasticity (QPS).’MethodsUsing a semi-structured interview guide, concept elicitation interviews on spasticity-related pain in upper and lower limbs were conducted in 21 children and caregiver pairs. Data were used to modify initial QPS modules and develop six draft modules, which were subsequently refined and finalized in four consecutive cognitive interview waves (12 children and caregiver pairs).ResultsTo accommodate the broad range in the children’s communication skills, QPS child/adolescent modules were developed in both interviewer-administered and self-administered formats. With the additional parent modules, three QPS modules were developed for each of the upper and lower limb applications. Information gained from the parent/caregiver modules complements the child/adolescent assessment. Parents report observed signs and frequency of pain in the same situations used to capture the child/adolescent reports of pain severity (e.g., rest, usual daily activities, active mobilization, and physically difficult activities). Participating children/adolescents and parents/caregivers reported that the final QPS instruments were comprehensive, relevant to the child’s spasticity-related experience, and easy to understand and complete.ConclusionsThe QPS is a novel instrument for the assessment of spasticity-related pain in children/adolescents with CP that was developed with direct patient input. Its modules allow the use of this instrument in children/adolescents with varied levels of impairment and communication skills.

Highlights

  • Cerebral palsy (CP) is a motor impairment condition caused by damage to the developing brain [1, 2]

  • The Questionnaire on Pain caused by Spasticity’ (QPS) is a novel instrument for the assessment of spasticity-related pain in children/adolescents with cerebral palsy (CP) that was developed with direct patient input

  • Even when intramuscular injections of botulinum toxin are currently recommended for pediatric patients with CP [8, 13, 14], most clinical studies conducted in children/adolescents have been small and outcome measures have not been consistent or developed for children with CP

Read more

Summary

Introduction

Cerebral palsy (CP) is a motor impairment condition caused by damage to the developing brain [1, 2]. In pediatric patients with spasticity, assessments and therapeutic interventions commonly focus on motor symptoms, but spasticity-related pain (SRP) is often underreported and undertreated [3,4,5,6,7]. Growing evidence suggests that in adults with spasticity, SRP can be decreased by botulinum toxin injections [11, 12]. Even when intramuscular injections of botulinum toxin are currently recommended for pediatric patients with CP [8, 13, 14], most clinical studies conducted in children/adolescents have been small and outcome measures have not been consistent or developed for children with CP

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call